Skip to content

Construction of spatio-temporal homogenous rehabilitation training model and its effect on executive impairment of cerebral infarction

Construction of spatio-temporal homogenous rehabilitation training model and its effect on executive impairment of cerebral infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17013459
Enrollment
Unknown
Registered
2017-11-20
Start date
2017-06-30
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

Control:Anti platelet aggregation drug treatment, lipid-lowering drug treatment, neurotrophic drugs treatment, improve circulation drugs, clear free radical drugs + routine executive function rehabili
Experimental:Anti platelet aggregation drug treatment, lipid-lowering drug treatment, neurotrophic drugs treatment, improve circulation drugs, clear free radical drugs + The rehabilitation training of

Sponsors

Gansu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of stroke, and confirmed by CT or MRI; 2. The first incidence,Course of disease=3 months; 3. Imaging examination showed no moderate or more brain atrophy or leukoaraiosis, no visual field defect and visual space neglect; 4. Checked by the simple mental status checklist, there is cognitive impairment; 5. The connection test, screening for the implementation of dysfunction; 6. Aged 50 to 70 years old. patients;?Consciousness;?All vital signs were stable, and no progress of cerebral infarction persisted for more than 2 days.?Past dementia and psychiatric history, basic self-care life;?Patients and their families informed consent.

Exclusion criteria

Exclusion criteria: 1. large areas of cerebral infarction and brain stem infarction; 2. complicated with myocardial infarction or severe liver and kidney dysfunction, severe infection, severe diabetes; 3. serious communication and exchange of speech barriers; 4. Complicated with a serious half space overlooked; 5. taking drugs to improve cognitive impairment related persons;are participating in other related patients who perform dysfunction studies; 6. Been participating in other related executive function disorder patients in the study; 7. Been participating in executive dysfunction in patients with other relevant research; 8. After repeated guidance can not complete the scale inspection.

Design outcomes

Primary

MeasureTime frame
Minimum mental state Examination;Montreal Cognitive Assessment;Trail Making Test;Activity of daily living Scale;chronic disease self-efficacy scale;

Countries

China

Contacts

Public ContactZhang Yanqin

Gansu Provincial Hospital of Chinese Medicine

304161079@qq.com+86 15002591768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026